Head to head
Methylene Blue against MitoQ
Two things taken for mitochondrial function with different risks attached. Methylene blue is a monoamine oxidase inhibitor with documented fatal interactions with antidepressants; MitoQ failed mouse lifespan testing and improved vascular function in a randomised trial of 20 healthy older adults.
Column A
Methylene BlueMethylene blue (methylthioninium chloride)
An FDA-approved antidote for methemoglobinemia that biohackers take at low doses for mitochondrial energy and focus; the cognitive evidence is thin and it is a monoamine oxidase inhibitor with documented fatal interactions with antidepressants.
Column B
MitoQMitoQ (mitoquinone mesylate), mitochondria-targeted antioxidant
A widely sold mitochondrial antioxidant that failed mouse lifespan testing, and that did improve vascular function in a randomised trial of 20 healthy older adults.
Side by side, on the facts we can check
| Attribute | Methylene Blue | MitoQ |
|---|---|---|
| Category | Antioxidant | Antioxidant |
| FDA status | FDA-approved for methemoglobinemia only (ProvayBlue); other uses are off-label or unapproved | Sold as a dietary supplement in the United States. Not approved to prevent or treat anything. |
| Half-life | ~5 to 6 hours (oral) | Not asserted. No reliable human half-life figure was resolved in the sources loaded. Mitochondrial accumulation means tissue kinetics differ substantially from plasma kinetics. |
| Molecular weight | 319.9 Da | Roughly 665 Da for the mesylate salt. A small molecule, not a peptide. |
| Mechanism | Redox cycling that shuttles electrons within the mitochondrial respiratory chain, plus reversible inhibition of monoamine oxidase A and nitric-oxide synthase. | A ubiquinone moiety, the same redox-active head group as coenzyme Q10, covalently attached to a triphenylphosphonium cation. That lipophilic cation accumulates several hundred-fold inside mitochondria, driven by the negative membrane potential across the inner membrane. So unlike ordinary antioxidants, which distribute broadly, MitoQ concentrates where mitochondrial superoxide is produced. Note that it is not a coenzyme Q10 substitute: it does not participate in the respiratory chain as an electron carrier, because the targeting group interferes with that role. |
| Human studies cited | 3 | 1 |
| Legal status, US | Prescription drug for methemoglobinemia; 'supplement' products are unapproved | Sold as a supplement |
Frequently asked questions
What is the difference between Methylene Blue and MitoQ?
Methylene Blue: An FDA-approved antidote for methemoglobinemia that biohackers take at low doses for mitochondrial energy and focus; the cognitive evidence is thin and it is a monoamine oxidase inhibitor with documented fatal interactions with antidepressants. MitoQ: A widely sold mitochondrial antioxidant that failed mouse lifespan testing, and that did improve vascular function in a randomised trial of 20 healthy older adults.
Which has stronger research evidence, Methylene Blue or MitoQ?
This database does not grade compounds. It counts what was run in people: 3 of the 4 studies cited on the Methylene Blue profile were human work, against 1 of 2 for MitoQ. Those counts are of our own citation lists and understate any larger literature, and neither is a recommendation.
Are Methylene Blue and MitoQ FDA-approved?
Methylene Blue: FDA-approved for methemoglobinemia only (ProvayBlue); other uses are off-label or unapproved. MitoQ: Sold as a dietary supplement in the United States. Not approved to prevent or treat anything..
Related posts
Blog articles that cover Methylene Blue or MitoQ, newest first.
Reviewed Sep 2026. This page sets two published records side by side. It is educational, it is not medical advice, and it contains no dosing protocols or recommendations for personal use.